“Game changer” for the cannabis sector as first cannabis company set to list on LSE, with Herzog Fox & Neeman support
Up until recently, regulations surrounding the public listing of cannabis firms has been unclear. However, since the FCA released a set of rules in September 2020, cannabis companies were quick to set things in motion.
Herzog Fox & Neeman has been advising Tel Aviv-based Kanabo, which has developed the world’s first medicinal cannabis vapourising device, which delivers a metered dose of cannabis extract.
Smoking cannabis flower is a popular administration method for those suffering with chronic pain, however it gives a different dose on every inhale which prevents medical professionals from accepting smoking as a medicinal delivery method.
Kanabo’s VapePod, which can deliver a metered dose has already had initial sales in a pilot in the UK and Germany. They are expecting that the CE mark for the second-generation medical device will be given in the first or second quarter of this year.
